PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules

被引:0
|
作者
Shibo Qi
Susan Hoppmann
Yingding Xu
Zhen Cheng
机构
[1] Tianjin Polytechnic University,School of Environmental and Chemical Engineering
[2] Stanford University,Molecular Imaging Program at Stanford (MIPS), Department of Radiology, and Bio
来源
Molecular Imaging and Biology | 2019年 / 21卷
关键词
PET; Affibody; HER2; Cu-64; Tumor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:907 / 916
页数:9
相关论文
共 50 条
  • [41] A novel 18F-labeled two-helix scaffold protein for PET imaging of HER2-positive tumor
    Zheng Miao
    Gang Ren
    Lei Jiang
    Hongguang Liu
    Jack M. Webster
    Rong Zhang
    Mohammad Namavari
    Sanjiv S. Gambhir
    Faisal Syud
    Zhen Cheng
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 1977 - 1984
  • [42] A novel 18F-labeled two-helix scaffold protein for PET imaging of HER2-positive tumor
    Miao, Zheng
    Ren, Gang
    Jiang, Lei
    Liu, Hongguang
    Webster, Jack M.
    Zhang, Rong
    Namavari, Mohammad
    Gambhir, Sanjiv S.
    Syud, Faisal
    Cheng, Zhen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (11) : 1977 - 1984
  • [43] Feasibility of radionuclide imaging of HER3-expressing tumors using affibody molecules
    Orlova, Anna
    Malm, Magdalena
    Lindberg, Hanna
    Varasteh, Zohreh
    Rosestedt, Maria
    Tolmachev, Vadimir
    Kronqvist, Nina
    Stahl, Stefan
    Lofblom, John
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S11 - S11
  • [44] 64Cu Radiolabeled PDGFRβ-Targeting Affibody for PET Imaging in Pancreatic Cancer
    Li, Zhao
    Geng, Ruiman
    Zhan, Yousheng
    Liu, Ruomeng
    Li, Mufeng
    Ke, Nengwen
    Yang, Hao
    Lu, Xiaofeng
    Li, Lin
    Li, Suping
    Cai, Huawei
    MOLECULAR PHARMACEUTICS, 2025, 22 (03) : 1633 - 1640
  • [45] HER2-positive tumor imaging using heterobivalent scFv-affibody fusion protein and a universal hapten imaging probe
    Kim, Hye-Yeong
    Wang, Xiaolei
    Wahlberg, Brendon
    Edwards, W. Barry
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [46] PET/CT IMAGING OF 64CU-LABELLED HER2 LIPOSOMAL DOXORUBICIN (64CU-MM-302) QUANTIFIES VARIABILITY OF LIPOSOMAL DRUG DELIVERY TO DIVERSE TUMOR LESIONS IN HER2-POSITIVE BREAST CANCER PATIENTS
    Hendriks, B.
    Shields, A.
    Siegel, B. A.
    Miller, K.
    Munster, P.
    Ma, C.
    Campbell, K.
    Moyo, V.
    Wickham, T.
    LoRusso, P.
    ANNALS OF ONCOLOGY, 2014, 25 : 19 - 19
  • [47] Evaluation of the first 44Sc-labeled Affibody molecule for imaging of HER2-expressing tumors
    Honarvar, Hadis
    Muller, Cristina
    Cohrs, Susan
    Haller, Stephanie
    Westerlund, Kristina
    Karlstrom, Amelie Eriksson
    van der Meulen, Nicholas P.
    Schibli, Roger
    Tolmachev, Vladimir
    NUCLEAR MEDICINE AND BIOLOGY, 2017, 45 : 15 - 21
  • [48] Site-Specific, Platform-Based Conjugation Strategy for the Synthesis of Dual-Labeled Immunoconjugates for Bimodal PET/NIRF Imaging of HER2-Positive Tumors
    Adumeau, Pierre
    Raave, Rene
    Boswinkel, Milou
    Heskamp, Sandra
    Wessels, Hans J. C. T.
    van Gool, Alain J.
    Moreau, Mathieu
    Bernhard, Claire
    Da Costa, Laurene
    Goncalves, Victor
    Denat, Franck
    BIOCONJUGATE CHEMISTRY, 2022, 33 (03) : 530 - 540
  • [49] SMALL ANIMAL PET IMAGING OF TUMORS WITH 64CU-LABELED RGD-BOMBESIN HETERODIMER
    Liu, Z.
    Li, Z.
    Cao, Q.
    Liu, S.
    Wand, F.
    Chen, X.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S226 - S226
  • [50] HER2-Positive Tumors Imaged Within 1 Hour Using a Site-Specifically 11C-Labeled Sel-Tagged Affibody Molecule
    Wallberg, Helena
    Grafstrom, Jonas
    Cheng, Qing
    Lu, Li
    Ahlzen, Hanna-Stina Martinsson
    Samen, Erik
    Thorell, Jan-Olov
    Johansson, Katarina
    Dunas, Finn
    Olofsson, Maria Hagg
    Stone-Elander, Sharon
    Arner, Elias S. J.
    Stahl, Stefan
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (09) : 1446 - 1453